A teenager with measles on a trip from New Zealand visited Disneyland, Universal Studios, Madame Tussauds, and the Santa Monica Pier earlier this month, potentially exposing large numbers of people to the disease, in today's bite-sized hospital and health industry news from California, Connecticut, and Tennessee.
Dawn Patterson and two of her children suffer from a rare bone disease, the only treatment for which is a multimillion-dollar drug that was slated to cost $6 million a year—a high price tag that's indicative of the pharmaceutical industry's growing interest in treatment for rare diseases, Katie Thomas and Reed Abelson report for the New York Times.
Many Medicare beneficiaries admitted into long-term acute care hospitals spend about 66% of their remaining lives in an inpatient setting, and many die within five years, according to a study published Monday in the Journal of the American Geriatrics Society.
The Drug Enforcement Administration on Monday announced that it will move forward with a years-delayed expansion of the agency's marijuana research program, meaning the agency soon could permit more growers to produce marijuana for use in medical studies and other research.
It has been widely speculated that the reason the United States outspends other countries on health care is because it does not invest enough in social services, but a study published last week in Health Affairs casts doubt on that theory.
Back from your summer vacation and ready to excel at work in the fall? Advisory Board experts reveal their tried-and-true workplace secrets to warding off burnout, offering better advice, getting better feedback, and winning over your coworkers.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.